PDT Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.05M Hold
9,559
0.06% 331
2025
Q4
$1.59M Sell
9,559
-700
-7% -$117K 0.1% 287
2025
Q3
$2.01M Sell
10,259
-114,383
-92% -$18.8M 0.13% 252
2025
Q2
$11.3M Buy
124,642
+71,485
+134% +$5.65M 0.64% 14
2025
Q1
$3.17M Buy
53,157
+28,121
+112% +$2.6M 0.23% 150
2024
Q4
$3.32M Sell
25,036
-9,964
-28% -$935K 0.29% 113
2024
Q3
$1.83M Buy
+35,000
New +$1.64M 0.16% 229

Other funds holding ALAB

PDT Partners's ALAB Position: Q1 2026 in Review

PDT Partners held its Astera Labs (ALAB) position steady in Q1 2026 at 9,559 shares worth $1.05M. The position accounts for 0.06% of the portfolio, ranked #331.

PDT Partners first reported a position in ALAB in Q3 2024 and has held it in 7 quarters since. The position peaked at $11.3M in Q2 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • PDT Partners held 9,559 shares of Astera Labs worth $1.05M as of Q1 2026.
  • PDT Partners left its Astera Labs share count unchanged in Q1 2026.
  • Astera Labs made up 0.06% of PDT Partners's portfolio in Q1 2026, its #331 holding.
  • PDT Partners first reported a position in Astera Labs in Q3 2024 and has held it in 7 quarters since.
  • PDT Partners's Astera Labs position peaked at $11.3M in Q2 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.